Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × IFL protocol × Tumor-Agnostic × Clear all

Phase

Status

Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

pembrolizumab 18 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Bevacizumab 8 Nivolumab 7 Paclitaxel 6 Biopsy 6 atezolizumab 5 Ipilimumab 5 Cyclophosphamide 5 Practice Guidelines as Topic 4 Oxaliplatin 4 osimertinib 3 olaparib 3 niraparib 3 durvalumab 3 cemiplimab 3 avelumab 3 X-Rays 3 Surveys and Questionnaires 3 Standard of Care 3 Radiotherapy 3 Radiosurgery 3 Radiation 3 Pemetrexed 3 Leucovorin 3 Irinotecan 3 Interviews as Topic 3 Fluorouracil 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03806309 2025-07-25

TEDOPAM

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Active not recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡